Inactive

This notice is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation ... This notice is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and Solicitation for Commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation document will not be issued. Submit offers on RFQ-RML-C-2088052 This solicitation is a request for quotes (RFQ). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2021-06 Effective July 12, 2021 The associated North American Industry Classification System (NAICS) code for this procurement is 325414 with a small business size standard of 1250 employees. This acquisition is being posted as a Brand Name Restriction with “No” small business set-aside. The National Institute of Allergy and Infectious Diseases (NIAID), The Laboratory of Virology at Rocky Mountain Laboratories is seeking to purchase Immunogenomics 10x B-cell Single Cell Immuno-Profiling and related services. The Viral Pathogenesis Section (VPS) routinely surveys the dynamics of B-cell responses following Zika virus (or other heterologous flavivirus) infection or vaccination. We need efficient, accurate, sensitive and prompt ultra-deep sequencing and customized bioinformatics to provide comprehensive characterization of the immense diversity of B-cell receptors (BCR) repertoire, including the ability to pair heavy and light BCR chains at single-cell resolution. Genewiz 10X B-cell Single Cell Immuno-Profiling and related services includes single cell isolation via microfluidic technology with up to 65% cell capture efficiency and subsequent indexed sequencing on Illumina Sequencing 10X Configuration. Sequencing would include the processing of about 6,000 cells per sample, with 5,000 total number of reads per cell. They also offer a proprietary cell freezing protocol that maintains cell viability and the company also performs a dead cell removal process that improves data quality. Service includes Ph.D.-level consultation providing guidance before, during and after the project, as well as the automated mining of data to yield easy-to-interpret results that reduces analysis time for the researcher. Additionally, large data files are stored for up to six months and can easily be accessed and analyzed by 10x Genomics Cell Ranger and Loupe Cell Browser allowing for customization of the sequencing results and easy sequence transfer for downstream DNA gene synthesis, if needed. Additionally, the service can be paired with other Genewiz services such as Bulk Immuno-profiling and downstream DNA gene synthesis that streamlines data processing and analysis from a single study. Statement of Work This statement of work is for the procurement of Immunogenomics 10x B-cell Single Cell Immuno-Profiling and related services. The Viral Pathogenesis Section (VPS) routinely surveys the dynamics of B-cell responses following Zika virus (or other heterologous flavivirus) infection or vaccination. We need efficient, accurate, sensitive and prompt ultra-deep sequencing and customized bioinformatics to provide comprehensive characterization of the immense diversity of B-cell receptors (BCR) repertoire, including the ability to pair heavy and light BCR chains at single-cell resolution. Our specific requirements are enumerated below: 1. Government shall provide at least 50,000 cells in 0.5 mL aliquot per sample, submitted in duplicate as frozen single cell suspension with at least 90% cellular viability after thawing. 2. Vendor shall provide cryopreservation protocol to aid shipment of samples. 3. Vendor shall be able to perform single cell isolation via microfluidic technology with up to 65% cell capture efficiency. 4. Vendor must perform initial sample QC free of charge, including the following: a. Assessing RNA integrity by Tapestation and concentration by Qubit assay b. Assessing library size on the Agilent Tapestation, concentration by Qubit assay, and final quantitation by qPCR. 5. Vendor shall perform indexed sequencing on Illumina Sequencing 10x Configuration targeting BCR genes in pre-defined primer sets. 6. Vendor shall perform sequencing in about 6,000 cells per sample. 7. Sequencing yield shall be about 5,000 total number of reads per cell. 8. Multiplexing of samples must be performed such that samples are run on the same chip whenever possible. 9. Vendor shall supply quality reports, FASTQ files and bioinformatic tools, including interactive V(D)J analysis through the 10x Genomics Cell Ranger and Loupe Cell Browser. 10. Vendor must provide a dedicated PhD-level Study Manager and weekly project updates. 11. Vendor must offer sample storage for at least one year following project completion. 12. Vendor must offer data storage of FASTQ files for up to 6 months. 13. data files shall be stored for six months and must be accessed/analyzed easily by 10x Genomics Cell Ranger and Loupe Cell Browser. Allowing for customization of the sequencing results and easy sequence transfer for downstream DNA gene synthesis, if needed. 14. This service shall be capable of being paired with other Genewiz services. For Example, Bulk Immuno-profiling and downstream DNA gene synthesis that streamlines data processing and analysis from a single study. PLEASE INCLUDE: MANUFACTURER COUNTRY OF ORIGIN ESTIMATED COMPLETION OF SERVICE APPLICABLE SHIPPING CHARGES TO NIH LOCATED IN BETHESDA, MD FOB - DESTINATION To be considered for award must meet all criteria within the Statement of Work listed above. • Place of Performance: NIH NIAID 33 North Drive Bethesda, MD 20892 Each response must clearly indicate the capability of the vendor to meet all requirements and services requested within the solicitation. Provide past services of similar services performed. The Government may evaluate only those quotes that fully meet the requirements as outlined above and respond to the solicitation instructions and requirements. Failure to furnish a full and complete quote as instructed may result in the Vendor’s response being considered non-responsive and will therefore be eliminated from further consideration and award. I. EVALUATION: NIAID will evaluate all quotes to determine the most advantageous to the government. NIAID will make that determination based on the capability of each vendor’s quote to provide all requested products/services, meet the brand name requirements, provide the proposed products/service in a timely manner, warranty, and reasonable price. The Government’s objective is to obtain the highest technical solution considered necessary to achieve the project objectives with a reasonable price. In the event quotes are evaluated as equal in non-price factors, price or cost will become a major consideration in selecting the successful Vendor II. SPECIAL NOTICE TO VENDORS Vendors are advised that the Government may share your information with non-government personnel who are assisting with the evaluation of quotes. The exclusive responsibility for source selection will reside with the Government. By submitting your quote, you will be consenting to disclosure of your quote to non-government personnel for purposes of evaluation. PROVISIONS AND CLAUSES The government intends to award a single firm, fixed price purchase order as a result of this solicitation that will include the terms and conditions set forth herein. The following FAR and HHSAR provisions and clauses apply to this acquisition: The following Federal Acquisition Regulations (FAR) provisions and clauses are incorporated by reference and full text versions may be accessed electronically at: https://www.acquisition.gov/far/. The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (July 2021) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (FEB 2021) FAR 52.204-7 System for Award Management (Oct 2018) (Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (Jan 2017) 52.204–26 Covered Telecommunications Equipment or Services-Representation (OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26 The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (OCT 2018) FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (JULY 2021) *The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting. FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013) FAR 52.204-13 System for Award Management Maintenance (Oct 2018) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015) 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. Submission shall be received not later than September 19, 2021 @ 8:00 am EST Offers may be e-mailed to Diana Rohlman, diana.rohlman@nih.gov. Offers shall include RFQ number in the subject line (RFQ-RM-C-2088052) and include the appropriate DUNS number to use and manufacturer’s country of origin. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to diana.rohlman@nih.gov.